Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Genetic evidence from a new report suggests the coronavirus pandemic most likely spilled over from animals in the Wuhan ...

Health Canada authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against Jim Cramer’s other must-watch ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

Suddenly Australia has its newest technology unicorn with a coveted $1bn valuation; and there is no surprise artificial ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...